Biktarvy 50 mg/200 mg/25 mg film-coated tablets
GS-US-380-6738
Approved small_molecule active
Quick answer
Biktarvy 50 mg/200 mg/25 mg film-coated tablets for HIV-1 infection is a Approved program (small_molecule) at Gilead Sciences International Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Gilead Sciences International Limited
- Indication
- HIV-1 infection
- Phase
- Approved
- Modality
- small_molecule
- Status
- active